Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer. Read more about Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors. Read more about Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.
Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study. Read more about Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study.
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib. Read more about Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib.
The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors. Read more about The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors.
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score. Read more about Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score.
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Read more about Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
Willingness to use tamoxifen to prevent breast cancer among diverse women. Read more about Willingness to use tamoxifen to prevent breast cancer among diverse women.
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor. Read more about Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor.
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene. Read more about Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.
